Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 15-Apr-24 4:15 PM View:  | Ra Capital Management, LLC Director 10% Owner | 89bio, Inc. (ETNB) | 11-Apr-24 | Exercise (in-the money or at-the-money) | 1,408,450 | $5.32 | $7,500,000.00 | 11% 12.77M to 14.18M | |
| 03-Apr-24 4:01 PM View: | Palekar Rohan Chief Executive Officer Director | 89bio, Inc. (ETNB) | 01-Apr-24 | Sale (Planned) | 27,718 | $10.91 | $302,403.00 | (6%) 486.89K to 459.17K | |
| 03-Apr-24 4:01 PM View: | Palekar Rohan Chief Executive Officer Director | 89bio, Inc. (ETNB) | 01-Apr-24 | Option Exercise | 25,000 | $1.93 | $48,250.00 | 5% 486.89K to 511.89K | |
| 03-Apr-24 4:01 PM View: | Palekar Rohan Chief Executive Officer Director | 89bio, Inc. (ETNB) | 01-Apr-24 | Planned Option Sale | 25,000 | $10.91 | $272,750.00 | (5%) 511.89K to 486.89K | |
| 06-Mar-24 10:00 PM View: | Ra Capital Management, LLC Director 10% Owner | 89bio, Inc. (ETNB) | 04-Mar-24 | Purchase | 1,350,000 | $15.35 | $20,722,500.00 | 12% 11.42M to 12.77M | |
| 28-Feb-24 6:43 PM View: | Palekar Rohan Chief Executive Officer Director | 89bio, Inc. (ETNB) | 26-Feb-24 | Sale (Planned) | 4,477 | $10.76 | $48,172.50 | (< 1%) 491.37K to 486.89K | |
| 23-Feb-24 8:41 PM View: | Mansbach Harry H Chief Medical Officer | 89bio, Inc. (ETNB) | 17-Feb-24 | Payment of Exercise | 1,046 | $9.74 | $10,188.00 | (< 1%) 159.48K to 158.44K | |
| 23-Feb-24 8:55 PM View: | Martins Ryan Chief Financial Officer | 89bio, Inc. (ETNB) | 17-Feb-24 | Payment of Exercise | 778 | $9.74 | $7,577.72 | (< 1%) 107.39K to 106.61K | |
| 23-Feb-24 8:50 PM View: | Le-Nguyen Quoc See Remarks | 89bio, Inc. (ETNB) | 17-Feb-24 | Payment of Exercise | 1,046 | $9.74 | $10,188.00 | (< 1%) 223.19K to 222.15K | |
| 23-Feb-24 8:51 PM View: | Palekar Rohan Chief Executive Officer Director | 89bio, Inc. (ETNB) | 17-Feb-24 | Payment of Exercise | 4,602 | $9.74 | $44,823.50 | (< 1%) 495.97K to 491.37K | |
| 13-Feb-24 9:12 PM View: | Martins Ryan Chief Financial Officer | 89bio, Inc. (ETNB) | 09-Feb-24 | Payment of Exercise | 3,568 | $8.45 | $30,149.60 | (3%) 110.95K to 107.39K | |
| 13-Feb-24 9:02 PM View: | Le-Nguyen Quoc See Remarks | 89bio, Inc. (ETNB) | 09-Feb-24 | Payment of Exercise | 3,568 | $8.45 | $30,149.60 | (2%) 226.76K to 223.19K | |
| 13-Feb-24 8:58 PM View: | Palekar Rohan Chief Executive Officer Director | 89bio, Inc. (ETNB) | 09-Feb-24 | Payment of Exercise | 12,670 | $8.45 | $107,062.00 | (3%) 493.64K to 480.97K | |
| 13-Feb-24 9:04 PM View: | Mansbach Harry H Chief Medical Officer | 89bio, Inc. (ETNB) | 09-Feb-24 | Payment of Exercise | 3,568 | $8.45 | $30,149.60 | (2%) 163.05K to 159.48K | |
| 05-Feb-24 8:22 PM View: | Le-Nguyen Quoc See Remarks | 89bio, Inc. (ETNB) | 05-Feb-24 | Payment of Exercise | 1,190 | $9.80 | $11,662.00 | (< 1%) 227.95K to 226.76K | |
| 05-Feb-24 8:16 PM View: | Palekar Rohan Chief Executive Officer Director | 89bio, Inc. (ETNB) | 05-Feb-24 | Payment of Exercise | 5,068 | $9.80 | $49,666.40 | (1%) 498.71K to 493.65K | |
| 05-Feb-24 8:22 PM View: | Mansbach Harry H Chief Medical Officer | 89bio, Inc. (ETNB) | 05-Feb-24 | Payment of Exercise | 1,190 | $9.80 | $11,662.00 | (< 1%) 164.24K to 163.05K | |
| 05-Feb-24 8:07 PM View: | Martins Ryan Chief Financial Officer | 89bio, Inc. (ETNB) | 05-Feb-24 | Payment of Exercise | 892 | $9.80 | $8,741.60 | (< 1%) 111.85K to 110.95K | |
| 05-Feb-24 8:22 PM View: | Mansbach Harry H Chief Medical Officer | 89bio, Inc. (ETNB) | 01-Feb-24 | Grant | 48,750 | -- | -- | 42% 115.49K to 164.24K | |
| 05-Feb-24 8:07 PM View: | Martins Ryan Chief Financial Officer | 89bio, Inc. (ETNB) | 01-Feb-24 | Grant | 48,750 | -- | -- | 77% 63.1K to 111.85K | |
| 05-Feb-24 8:22 PM View: | Le-Nguyen Quoc See Remarks | 89bio, Inc. (ETNB) | 01-Feb-24 | Grant | 48,750 | -- | -- | 27% 179.2K to 227.95K | |
| 05-Feb-24 8:16 PM View: | Palekar Rohan Chief Executive Officer Director | 89bio, Inc. (ETNB) | 01-Feb-24 | Grant | 150,000 | -- | -- | 43% 348.71K to 498.71K | |
| 08-Jan-24 6:32 PM View: | Le-Nguyen Quoc See Remarks | 89bio, Inc. (ETNB) | 05-Jan-24 | Grant | 25,000 | -- | -- | 15% 163.87K to 188.87K | |
| 08-Jan-24 6:35 PM View: | Martins Ryan Chief Financial Officer | 89bio, Inc. (ETNB) | 05-Jan-24 | Payment of Exercise | 6,124 | $11.53 | $70,609.70 | (9%) 69.22K to 63.1K | |
| 08-Jan-24 6:32 PM View: | Le-Nguyen Quoc See Remarks | 89bio, Inc. (ETNB) | 05-Jan-24 | Payment of Exercise | 9,671 | $11.53 | $111,507.00 | (5%) 188.87K to 179.2K | |
| 08-Jan-24 6:31 PM View: | Palekar Rohan Chief Executive Officer Director | 89bio, Inc. (ETNB) | 05-Jan-24 | Grant | 75,000 | -- | -- | 25% 301.23K to 376.23K | |
| 08-Jan-24 7:00 PM View: | Mansbach Harry H Chief Medical Officer | 89bio, Inc. (ETNB) | 05-Jan-24 | Grant | 25,000 | -- | -- | 25% 100.16K to 125.16K | |
| 08-Jan-24 6:31 PM View: | Palekar Rohan Chief Executive Officer Director | 89bio, Inc. (ETNB) | 05-Jan-24 | Payment of Exercise | 27,511 | $11.53 | $317,202.00 | (7%) 376.23K to 348.71K | |
| 08-Jan-24 7:00 PM View: | Mansbach Harry H Chief Medical Officer | 89bio, Inc. (ETNB) | 05-Jan-24 | Payment of Exercise | 9,671 | $11.53 | $111,507.00 | (8%) 125.16K to 115.49K | |
| 08-Jan-24 6:35 PM View: | Martins Ryan Chief Financial Officer | 89bio, Inc. (ETNB) | 05-Jan-24 | Grant | 15,000 | -- | -- | 28% 54.22K to 69.22K | |
| 03-Jan-24 4:54 PM View: | Palekar Rohan Chief Executive Officer Director | 89bio, Inc. (ETNB) | 29-Dec-23 | Option Exercise | 50,000 | $1.93 | $96,500.00 | 17% 301.23K to 351.23K | |
| 03-Jan-24 4:54 PM View: | Palekar Rohan Chief Executive Officer Director | 89bio, Inc. (ETNB) | 29-Dec-23 | Planned Option Sale | 50,000 | $11.20 | $560,000.00 | (14%) 351.23K to 301.23K | |
| 12-Sep-23 4:05 PM View: | Le-Nguyen Quoc See Remarks | 89bio, Inc. (ETNB) | 09-Sep-23 | Payment of Exercise | 4,958 | $16.61 | $82,352.40 | (3%) 168.83K to 163.87K | |
| 12-Sep-23 4:06 PM View: | Mansbach Harry H Chief Medical Officer | 89bio, Inc. (ETNB) | 09-Sep-23 | Payment of Exercise | 3,821 | $16.61 | $63,466.80 | (4%) 103.98K to 100.16K | |
| 12-Sep-23 4:05 PM View: | Martins Ryan Chief Financial Officer | 89bio, Inc. (ETNB) | 09-Sep-23 | Payment of Exercise | 2,074 | $16.61 | $34,449.10 | (4%) 56.3K to 54.22K | |
| 21-Aug-23 5:45 PM View: | Martins Ryan Chief Financial Officer | 89bio, Inc. (ETNB) | 17-Aug-23 | Payment of Exercise | 753 | $15.46 | $11,641.40 | (1%) 57.05K to 56.3K | |
| 21-Aug-23 5:49 PM View: | Palekar Rohan Chief Executive Officer Director | 89bio, Inc. (ETNB) | 17-Aug-23 | Payment of Exercise | 4,501 | $15.46 | $69,585.50 | (1%) 305.45K to 300.95K | |
| 21-Aug-23 5:51 PM View: | Mansbach Harry H Chief Medical Officer | 89bio, Inc. (ETNB) | 17-Aug-23 | Payment of Exercise | 1,014 | $15.46 | $15,676.40 | (< 1%) 105.0K to 103.98K | |
| 21-Aug-23 5:51 PM View: | Mansbach Harry H Chief Medical Officer | 89bio, Inc. (ETNB) | 01-Aug-23 | Payment of Exercise | 577 | $15.64 | $9,024.28 | (< 1%) 105.57K to 105.0K | |
| 21-Aug-23 5:43 PM View: | Le-Nguyen Quoc See Remarks | 89bio, Inc. (ETNB) | 01-Aug-23 | Payment of Exercise | 1,591 | $15.53 | $24,700.70 | (< 1%) 170.42K to 168.83K | |
| 21-Aug-23 5:45 PM View: | Martins Ryan Chief Financial Officer | 89bio, Inc. (ETNB) | 01-Aug-23 | Payment of Exercise | 346 | $15.64 | $5,411.44 | (< 1%) 57.39K to 57.05K | |
| 18-Jul-23 6:04 PM View: | Laporte Kathleen Director | 89bio, Inc. (ETNB) | 17-Jul-23 | Option Sale | 12,500 | $18.80 | $235,000.00 | (100%) 12.5K to 0 | |
| 18-Jul-23 6:04 PM View: | Laporte Kathleen Director | 89bio, Inc. (ETNB) | 17-Jul-23 | Option Exercise | 12,500 | $2.64 | $33,000.00 | 100% 0 to 12.5K | |
| 05-Jul-23 10:00 PM View: | Le-Nguyen Quoc See Remarks | 89bio, Inc. (ETNB) | 30-Jun-23 | Grant | 8,334 | -- | -- | 5% 164.97K to 173.31K | |
| 05-Jul-23 10:00 PM View: | Palekar Rohan Chief Executive Officer Director | 89bio, Inc. (ETNB) | 30-Jun-23 | Payment of Exercise | 16,527 | $18.95 | $313,187.00 | (5%) 321.98K to 305.45K | |
| 05-Jul-23 10:00 PM View: | Mansbach Harry H Chief Medical Officer | 89bio, Inc. (ETNB) | 30-Jun-23 | Payment of Exercise | 2,882 | $18.95 | $54,613.90 | (3%) 108.46K to 105.57K | |
| 05-Jul-23 10:00 PM View: | Martins Ryan Chief Financial Officer | 89bio, Inc. (ETNB) | 30-Jun-23 | Grant | 5,834 | -- | -- | 11% 53.58K to 59.41K | |
| 05-Jul-23 10:00 PM View: | Le-Nguyen Quoc See Remarks | 89bio, Inc. (ETNB) | 30-Jun-23 | Payment of Exercise | 2,882 | $18.95 | $54,613.90 | (2%) 173.31K to 170.42K | |
| 05-Jul-23 10:00 PM View: | Martins Ryan Chief Financial Officer | 89bio, Inc. (ETNB) | 30-Jun-23 | Payment of Exercise | 2,018 | $18.95 | $38,241.10 | (3%) 59.41K to 57.39K | |
| 05-Jul-23 10:00 PM View: | Palekar Rohan Chief Executive Officer Director | 89bio, Inc. (ETNB) | 30-Jun-23 | Grant | 33,334 | -- | -- | 12% 288.64K to 321.98K |
